Alder's migraine drug meets main goal in late-stage study
June 27 Alder BioPharmaceuticals Inc said on Tuesday its experimental treatment to prevent episodic migraine met the main goal of reducing monthly migraine days in a late-stage study.
Feb 23 Teekay Corp
* Teekay Corporation reports fourth quarter and annual 2016 results
* Q4 adjusted loss per share $0.22
* Qtrly revenues $552.2 million versus $700.1 million
* Qtrly GAAP net loss $0.03 per share Source text for Eikon: Further company coverage:
LONDON, June 27 Uber said it had won the right to appeal against a court decision in favour of plans by a London regulator to impose new English reading and writing standards in a move which could deprive it of thousands of drivers.